Clinical Trial Update: Chemotherapy in Treating Patients With Myelodysplastic Syndrome Before Donor Stem Cell Transplant [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating chemotherapy in patients with myelodysplastic syndromes prior to donor stem cell transplantation has completed with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• De Novo Myelodysplastic Syndrome
• Myelodysplastic Syndrome
• Myelomonocytic Leukemia

Snippet

Sponsor: Fred Hutchinson Cancer Center | Conditions: Chronic Myelomonocytic Leukemia, de Novo Myelodysplastic Syndrome | Phase 2 | Status: COMPLETED | Results posted: 2024-02-15